Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 10—October 2024
Dispatch

Bluetongue Virus in the Iberian Lynx (Lynx pardinus), 2010–2022

Javier Caballero-Gómez, Marta Sánchez-Sánchez, Cristina Lorca-Oró, Isabel G. Fernández de Mera, Irene Zorrilla, Guillermo López, Rosa Rosell, Rebeca Grande-Gómez, Juan I. Montoya-Oliver, Javier Salcedo, Jorge Paniagua, Cristina Cano-Gómez, Moisés GonzálvezComments to Author , and Ignacio García-Bocanegra
Author affiliations: University of Cordoba, Cordoba, Spain (J. Caballero-Gómez, J. Paniagua, M. Gonzálvez, I. García-Bocanegra); Carlos III Health Institute, Madrid, Spain (J. Caballero-Gómez, I. García-Bocanegra); Institute for Game and Wildlife Research, Ciudad Real, Spain (M. Sánchez-Sánchez, I.G. Fernández de Mera); Campus de la Universitat Autònoma de Barcelona, Bellaterra, Spain (C. Lorca-Oró, R. Rosell); Junta de Andalucía, Malaga, Spain (I. Zorrilla, G. López); Generalitat de Catalunya, Barcelona, Spain (R. Rosell); Technical Assistance from the General Direction of the Natural Environment and Sustainable Development of the Board of Communities of Castilla La Mancha, Toledo, Spain (R. Grande-Gómez); Ministry for the Ecological Transition and the Demographic Challenge, Madrid (J.I. Montoya-Oliver); Junta de Andalucía, Seville, Spain (J. Salcedo); Spanish Ministry of Agriculture, Food and Fisheries, Madrid (C. Cano-Gómez); University of Murcia, Murcia, Spain (M. Gonzálvez).

Main Article

Table

Bluetongue virus seropositivity in Iberian lynxes (Lynx pardinus) sampled in the Iberian Peninsula during 2010–2022 by age, sex, life condition, sampling period, and region

Variable Seroprevalence, % (95% CI) No. positives/no. analyzed* p value†
Age
Yearling 4.5 (1.9–10.0) 5/112 <0.001
Subadult 6.0 (2.5–13.2) 5/83
Adult
 20.6 (14.7–28.0)
 29/141
Sex
F 7.5 (4.3–12.6) 12/161 0.016
M
 15.6 (10.1–21.8)
 26/167
Life condition
Captive 6.3 (3.1–12.5) 7/111 0.025
Free ranging
 14.0 (10.1–19.1)
 32/229
Sampling period‡
2010–2016 12.4 (7.8–19.2) 16/129 0.128
2017–2020 7.3 (3.9–13.2) 9/124
2021–2022
 16.1 (9.8–25.2)
 14/87
Sampling region
Central 6.8 (2.9–14.9) 5/74 0.009
South 17.8 (12.5–24.6) 27/152
Southwest 6.8 (3.3–13.4) 7/103

*Missing values excluded. †p<0.5 significant. ‡The frequency of seropositivity by sampling year was 16.7% (2/12) in 2010, 0% (0/1) in 2011, 11.1% (2/18) in 2012, 13.3% (2/15) in 2013, 0% (0/2) in 2014, 12.5% (3/24) in 2015, 12.3% (7/57) in 2016, 11.8% (4/34) in 2017, 13.3% (2/15) in 2018, 6.5% (2/31) in 2019, 2.3% (1/44) in 2020, 11.7% (9/77) in 2021, and 50.0% (5/10) in 2022.

Main Article

Page created: September 03, 2024
Page updated: September 23, 2024
Page reviewed: September 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external